Cencora, Inc.
$310.27
▼
-0.74%
2026-04-22 10:12:13
www.cencora.com
NYQ: COR
Explore Cencora, Inc. stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$13.74 B
Current Price
$310.27
52W High / Low
$377.54 / $271
Stock P/E
—
Book Value
$9.81
Dividend Yield
0.73%
ROCE
20.96%
ROE
1.33%
Face Value
—
EPS
—
Exp Qtr EPS
—
Sector
Healthcare
Industry
Medical Distribution
Employees
47,000
Beta
0.72
Debt / Equity
472.58
Current Ratio
0.92
Quick Ratio
0.55
Forward P/E
16.37
Price / Sales
0.19
Enterprise Value
$70.75 B
EV / EBITDA
14.26
EV / Revenue
0.22
Rating
Buy
Target Price
$402.92
EPS Forecast (FY)
—
Pros
- Healthy return on equity.
- Efficient use of capital employed.
- Meaningful dividend yield is available.
Cons
- Leverage is relatively high.
- Current ratio suggests tighter short-term liquidity.
- Operating margin is thin.
- Net margin is relatively low.
- Valuation is rich on a P/E basis.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | Cosmos Health Inc. | $0.38 | — | $20.65 M | — | -53.42% | -63.82% | $1.32 / $0.28 | $0.73 |
| 2. | Henry Schein, Inc. | $78.73 | 24.1 | $9.06 B | — | 9.49% | 8.7% | $89.29 / $61.95 | $28.03 |
| 3. | Synergy CHC Corp. | $0.51 | — | $5.93 M | — | -93.25% | 62.08% | $4 / $0.42 | $-0.73 |
| 4. | Cardinal Health, Inc. | $202.95 | 29.15 | $47.74 B | 0.95% | 16.32% | -52.09% | $233.6 / $129.52 | $-12.22 |
| 5. | Empro Group Inc. | $17.36 | — | $144.63 M | — | 39.59% | 66.26% | $18.14 / $2.55 | $1.02 |
| 6. | McKesson Corporation | $837.14 | 24.1 | $102.52 B | 0.38% | 35.58% | -162.92% | $999 / $637 | $-10.55 |
| 7. | Accendra Health, Inc. | $3.52 | — | $270.97 M | — | 14.74% | -1.64% | $9.55 / $1.84 | $-6.04 |
Quarterly Results
Figures shown in M / B
| Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | |
|---|---|---|---|---|---|
| Sales | 85.93 B | 83.73 B | 80.66 B | 75.45 B | 81.49 B |
| Operating Profit | 1.02 B | 945.94 M | 980.24 M | 1.2 B | 807.49 M |
| Net Profit | 559.65 M | -339.7 M | 687.4 M | 717.87 M | 488.6 M |
| EPS in Rs | 2.88 | -1.75 | 3.53 | 3.69 | 2.51 |
Profit & Loss
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Sales | 321.33 B | 293.96 B | 262.17 B | 238.59 B |
| Operating Profit | 3.93 B | 3.16 B | 2.69 B | 2.75 B |
| Net Profit | 1.55 B | 1.51 B | 1.75 B | 1.7 B |
| EPS in Rs | 7.99 | 7.76 | 8.97 | 8.73 |
Balance Sheet
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Total Assets | 76.59 B | 67.1 B | 62.56 B | 56.56 B |
| Total Liabilities | 74.84 B | 66.31 B | 61.89 B | 56.49 B |
| Equity | 1.51 B | 645.94 M | 522 M | -211.56 M |
| Current Assets | 52.24 B | 47.72 B | 42.8 B | 39.59 B |
| Current Liabilities | 57.82 B | 54.28 B | 48.83 B | 43.48 B |
Cash Flow
Last available yearly cash flow history
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Operating CF | 3.88 B | 3.48 B | 3.91 B | 2.7 B |
| Investing CF | -4.98 B | -618.1 M | -2.6 B | -368.44 M |
| Financing CF | 2.25 B | -2.33 B | -2.22 B | -1.75 B |
| Free CF | 3.21 B | 3 B | 3.45 B | 2.21 B |
| Capex | -667.98 M | -487.17 M | -458.36 M | -496.32 M |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Revenue Growth % | 12.12% | 9.89% | — | — |
| Earnings Growth % | -13.53% | 2.74% | — | — |
| Profit Margin % | 0.51% | 0.67% | 0.71% | — |
| Operating Margin % | 1.07% | 1.02% | 1.15% | — |
| Gross Margin % | 3.37% | 3.42% | 3.48% | — |
| EBITDA Margin % | 1.15% | 1.29% | 1.3% | — |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
| Ex Date | Dividend |
|---|---|
| 2026-02-13 | $0.6 |
| 2025-11-14 | $0.6 |
| 2025-08-15 | $0.55 |
| 2025-05-16 | $0.55 |
| 2025-02-14 | $0.55 |
Stock Splits
No stock split history available.